Found 1143 matching trials
A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine PHASE1 N-cadherin, a protein involved in blood vessel cell binding, is increased a...
Show More Location
Rocky Mountain Cancer Centers
Learn More & Join Trial
Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer N/A This is a Retrospective, Multicenter, Controlled Study to Evaluate Immunoth...
Show More Location
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430030, Hubei, P. R. China
Learn More & Join Trial
A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors PHASE1 N-cadherin, a protein involved in blood vessel cell binding, is increased a...
Show More Location
University of Texas M.D. Anderson Cancer Center
Learn More & Join Trial
Adverse Drug Reactions to Cancer Therapies in Patients with Depression: Insights from VigiBase N/A Importance:
Depression is prevalent among oncology patients and may influe...
Show More Location
Caen University Hospital
Learn More & Join Trial
PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial PHASE2 This is a randomized controlled trial to determine the efficacy and safety ...
Show More Location
People's Hospital of Kaiyang County
Learn More & Join Trial
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors PHASE1 The primary objective of this study was to determine the safety and tolerab...
Show More Learn More & Join Trial
Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA NA The purpose of the study is to determine the diagnostic role of ctDNA when ...
Show More Location
Asst Papa Giovanni Xxiii- Bergamo
Learn More & Join Trial
ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer PHASE2 The efficacy of combining TKI with PD-1 inhibitor in the treatment of advan...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer NA Surgery with or without neoadjuvant therapy is usually used as the treatmen...
Show More Location
The Second Hospital of Shandong University
Learn More & Join Trial
Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma PHASE2 This multicenter, randomized, open-label, blinded-endpoint Phase II trial a...
Show More Location
Daping Hospital Third Military Medical University, chongqing, chongqing 400000 Recruiting
Learn More & Join Trial